Table 1.

Demographic and disease characteristics of the cohort with psoriatic arthritis.

CharacteristicMean (± SD)
Age, yrs47.5 (± 12.4)
Sex, % female48
Duration of illness, yrs8.2 (± 6.8)
Tender joint count, 0–683.98 (± 5.22)
Swollen joint count, 0–661.84 (± 2.67)
Damaged joint count, 0–683.07 (± 4.49)
Dactylitis, 0–200.33 (± 0.95)
MASES, 0–131.37 (± 2.30)
ESR, mm/h31.7 (± 28.1)
DAS283.8 (± 1.5)
Pain, 0–104.78 (± 2.57)
PGA, 0–104.56 (± 2.32)
MDGA, 0–102.06 (± 1.98)
HAQ, 0–30.62 (± 0.60)
PASI, 0–725.48 (± 7.33)
SF-36 PCS39.89 (± 9.43)
SF-36 MCS43.03 (± 11.49)
  • MASES: Maastricht Ankylosing Spondylitis Entheses Score; ESR: erythrocyte sedimentation rate; PGA: patient’s global assessment of disease activity; MDGA: physician’s global assessment of disease activity; HAQ: Health Assessment Questionnaire; PASI: Psoriasis Area and Severity Index; SF-36 PCS: physical component summary score of Medical Outcomes Study Short Form-36; SF-36 MCS: mental component summary score of SF-36.